Isofol Medical is a biotech company that focuses on a cancer drug. It develops Arfolitixorin to treat colorectal cancer. Arfolitixorin can potentially be used as a therapy after high-dose chemotherapy with methotrexate in conjunction with osteosarcoma (bone cancer) and as the treatment of pancreatic cancer, breast cancer, stomach cancer, and head and neck cancers.